WFS1 protein expression correlates with clinical progression of optic atrophy in patients with Wolfram syndrome. (2022)
Attributed to:
Development of a novel repurposed drug treatment for the neurodegeneration and diabetes in Wolfram syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jmedgenet-2020-107257
PubMed Identifier: 34006618
Publication URI: http://europepmc.org/abstract/MED/34006618
Type: Journal Article/Review
Volume: 59
Parent Publication: Journal of medical genetics
Issue: 1
ISSN: 0022-2593